MediPal Holdings Corporation (FRA:59Z)

Market Cap	3.31B +5.4%
Revenue (ttm)	20.80B +4.2%
Net Income	250.91M +14.0%
EPS	1.22 +15.7%
Shares Out	n/a
PE Ratio	13.17
Forward PE	n/a
Dividend	0.43 (2.69%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	16.00
Previous Close	16.80
Day's Range	15.90 - 16.00
52-Week Range	13.50 - 16.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About MediPal Holdings

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1898
• Employees: 13,024
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 59Z

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error